Latest Affinity Asset Advisors, LLC Stock Portfolio
$547Million
Equity Portfolio Value
Last Reported on: 13 Feb, 2024
About Affinity Asset Advisors, LLC and it’s 13F Hedge Fund Stock Holdings
Affinity Asset Advisors, LLC is a hedge fund based in New York, NY. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $237.6 Millions. In it's latest 13F Holdings report, Affinity Asset Advisors, LLC reported an equity portfolio of $547.5 Millions as of 31 Dec, 2023.
The top stock holdings of Affinity Asset Advisors, LLC are IMGN, CERE, CBAY. The fund has invested 7.6% of it's portfolio in IMMUNOGEN INC and 5.8% of portfolio in CEREVEL THERAPEUTICS HLDNG I.
The fund managers got completely rid off PROTHENA CORP PLC (PRTA), SEAGEN INC (SGEN) and LANTHEUS HLDGS INC (LNTH) stocks. They significantly reduced their stock positions in MORPHIC HLDG INC (MORF), TERNS PHARMACEUTICALS INC (TERN) and KURA ONCOLOGY INC (KURA). Affinity Asset Advisors, LLC opened new stock positions in IMMUNOGEN INC (IMGN), COMPASS PATHWAYS PLC (CMPS) and AXSOME THERAPEUTICS INC (AXSM). The fund showed a lot of confidence in some stocks as they added substantially to LIANBIO (LIAN), ALKERMES PLC (ALKS) and NUVALENT INC (NUVL).
The top stock holdings of Affinity Asset Advisors, LLC are IMGN, CERE, CBAY. The fund has invested 7.6% of it's portfolio in IMMUNOGEN INC and 5.8% of portfolio in CEREVEL THERAPEUTICS HLDNG I.
The fund managers got completely rid off PROTHENA CORP PLC (PRTA), SEAGEN INC (SGEN) and LANTHEUS HLDGS INC (LNTH) stocks. They significantly reduced their stock positions in MORPHIC HLDG INC (MORF), TERNS PHARMACEUTICALS INC (TERN) and KURA ONCOLOGY INC (KURA). Affinity Asset Advisors, LLC opened new stock positions in IMMUNOGEN INC (IMGN), COMPASS PATHWAYS PLC (CMPS) and AXSOME THERAPEUTICS INC (AXSM). The fund showed a lot of confidence in some stocks as they added substantially to LIANBIO (LIAN), ALKERMES PLC (ALKS) and NUVALENT INC (NUVL).
New Buys
| Ticker | $ Bought |
|---|---|
| IMMUNOGEN INC | 41,646,600 |
| COMPASS PATHWAYS PLC | 4,812,500 |
| AXSOME THERAPEUTICS INC | 3,979,500 |
| OMEROS CORP | 3,600,000 |
| COHERUS BIOSCIENCES INC | 3,403,160 |
| RELAY THERAPEUTICS INC | 3,303,000 |
| CULLINAN ONCOLOGY INC | 3,057,000 |
| ARGENX SE | 2,853,220 |
New stocks bought by Affinity Asset Advisors, LLC
Additions
Additions to existing portfolio by Affinity Asset Advisors, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| MORPHIC HLDG INC | -84.2 |
| TERNS PHARMACEUTICALS INC | -79.69 |
| KURA ONCOLOGY INC | -77.64 |
| MERSANA THERAPEUTICS INC | -64.91 |
| ASCENDIS PHARMA A/S | -56.9 |
| KRYSTAL BIOTECH INC | -56.52 |
| KALVISTA PHARMACEUTICALS INC | -54.73 |
| APOGEE THERAPEUTICS INC | -48.61 |
Affinity Asset Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| THESEUS PHARMACEUTICALS INC | -1,077,950 |
| TALARIS THERAPEUTICS INC | -1,124,000 |
| MILESTONE PHARMACEUTICALS IN | -1,038,710 |
| NLS PHARMACEUTICS LTD | -140,319 |
| BIOATLA INC | -306,000 |
| TRAVERE THERAPEUTICS INC | -894,000 |
| PROTHENA CORP PLC | -3,822,080 |
| ALDEYRA THERAPEUTICS INC | -296,245 |
Affinity Asset Advisors, LLC got rid off the above stocks
Current Stock Holdings of Affinity Asset Advisors, LLC
Last Reported on: 13 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 3.45 | 340,000 | 18,870,000 | REDUCED | -15.00 | |
| ADCT | ADC THERAPEUTICS SA | 0.31 | 1,013,540 | 1,682,480 | REDUCED | -7.86 | |
| AGLE | SPYRE THERAPEUTICS INC | 2.03 | 517,554 | 11,137,800 | ADDED | 113 | |
| ALDX | ALDEYRA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ALKS | ALKERMES PLC | 1.81 | 356,384 | 9,886,090 | ADDED | 256 | |
| ALLO | ALLOGENE THERAPEUTICS INC | 0.23 | 400,000 | 1,284,000 | NEW | ||
| APLS | APELLIS PHARMACEUTICALS INC | 0.82 | 75,000 | 4,489,500 | ADDED | 87.5 | |
| ARAV | ARAVIVE INC | 0.01 | 346,511 | 42,863 | UNCHANGED | 0.00 | |
| ARGX | ARGENX SE | 0.52 | 7,500 | 2,853,220 | NEW | ||
| ASND | ASCENDIS PHARMA A/S | 0.46 | 20,000 | 2,519,000 | REDUCED | -56.9 | |
| ATXS | ASTRIA THERAPEUTICS INC | 2.06 | 1,466,460 | 11,262,500 | ADDED | 46.6 | |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1.82 | 1,550,410 | 9,984,630 | REDUCED | -22.19 | |
| AVRO | AVROBIO INC | 0.12 | 500,000 | 680,000 | UNCHANGED | 0.00 | |
| AXSM | AXSOME THERAPEUTICS INC | 0.73 | 50,000 | 3,979,500 | NEW | ||
| AZN | ASTRAZENECA PLC | 0.74 | 60,000 | 4,041,000 | UNCHANGED | 0.00 | |
| BBIO | BRIDGEBIO PHARMA INC | 3.76 | 17,000,000 | 20,578,500 | UNCHANGED | 0.00 | |
| BBIO | BRIDGEBIO PHARMA INC | 0.59 | 80,000 | 3,229,600 | ADDED | 166 | |
| BCAB | BIOATLA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS INC | 4.70 | 1,090,440 | 25,756,200 | REDUCED | -3.45 | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | 5.81 | 750,000 | 31,800,000 | ADDED | 9.48 | |
| CGEM | CULLINAN ONCOLOGY INC | 0.56 | 300,000 | 3,057,000 | NEW | ||
| CHRS | COHERUS BIOSCIENCES INC | 0.62 | 6,000,000 | 3,403,160 | NEW | ||
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2.90 | 400,000 | 15,864,000 | ADDED | 166 | |
| CMPS | COMPASS PATHWAYS PLC | 0.88 | 550,000 | 4,812,500 | NEW | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1.16 | 795,729 | 6,334,000 | REDUCED | -21.84 | |
| CNTX | CONTEXT THERAPEUTICS INC | 0.07 | 328,817 | 371,563 | UNCHANGED | 0.00 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.90 | 447,095 | 15,907,600 | REDUCED | -0.65 | |
| CYTK | CYTOKINETICS INC | 2.44 | 160,000 | 13,358,400 | REDUCED | -30.55 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 0.77 | 300,000 | 4,194,000 | ADDED | 50.00 | |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 1.08 | 228,277 | 5,910,090 | REDUCED | -4.53 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 0.46 | 109,900 | 2,539,790 | NEW | ||
| FULC | FULCRUM THERAPEUTICS INC | 0.15 | 125,000 | 843,750 | NEW | ||
| IFRX | INFLARX NV | 0.06 | 200,097 | 326,158 | REDUCED | -38.45 | |
| IMGN | IMMUNOGEN INC | 7.61 | 1,404,610 | 41,646,600 | NEW | ||
| IMTX | IMMATICS N.V | 0.38 | 200,000 | 2,106,000 | UNCHANGED | 0.00 | |
| IMTX | IMMATICS N.V | 0.10 | 187,204 | 546,636 | UNCHANGED | 0.00 | |
| IMVT | IMMUNOVANT INC | 2.65 | 345,000 | 14,534,800 | ADDED | 15.00 | |
| INSP | INSPIRE MED SYS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| INZY | INOZYME PHARMA INC | 1.47 | 1,885,800 | 8,033,520 | ADDED | 36.67 | |
| KALV | KALVISTA PHARMACEUTICALS INC | 0.28 | 125,969 | 1,543,120 | REDUCED | -54.73 | |
| KRYS | KRYSTAL BIOTECH INC | 0.57 | 25,000 | 3,101,500 | REDUCED | -56.52 | |
| KURA | KURA ONCOLOGY INC | 0.50 | 191,535 | 2,754,270 | REDUCED | -77.64 | |
| LIAN | LIANBIO | 3.09 | 3,779,690 | 16,895,200 | ADDED | 462 | |
| LNTH | LANTHEUS HLDGS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 4.23 | 100,000 | 23,138,000 | ADDED | 17.65 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.27 | 50,000 | 1,476,000 | ADDED | 66.67 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.78 | 70,988 | 4,286,960 | ADDED | 41.98 | |
| MORF | MORPHIC HLDG INC | 0.22 | 42,670 | 1,232,310 | REDUCED | -84.2 | |
| MRSN | MERSANA THERAPEUTICS INC | 0.42 | 1,000,000 | 2,320,000 | REDUCED | -64.91 | |
| MRTX | MIRATI THERAPEUTICS INC | 1.07 | 100,049 | 5,877,880 | ADDED | 65.57 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 0.26 | 125,000 | 1,396,250 | UNCHANGED | 0.00 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 0.08 | 137,000 | 428,810 | UNCHANGED | 0.00 | |
| NARI | INARI MED INC | 0.24 | 20,000 | 1,298,400 | NEW | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 0.24 | 10,000 | 1,317,600 | NEW | ||
| NLSP | NLS PHARMACEUTICS LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NRIX | NURIX THERAPEUTICS INC | 1.30 | 690,112 | 7,121,960 | ADDED | 176 | |
| NUVB | NUVATION BIO INC | 0.07 | 250,000 | 377,500 | UNCHANGED | 0.00 | |
| NUVL | NUVALENT INC | 2.35 | 175,000 | 12,878,200 | ADDED | 250 | |
| OMER | OMEROS CORP | 0.66 | 6,000,000 | 3,600,000 | NEW | ||
| PBYI | PUMA BIOTECHNOLOGY INC | 0.16 | 202,349 | 876,171 | UNCHANGED | 0.00 | |
| PCVX | VAXCYTE INC | 0.29 | 25,000 | 1,570,000 | UNCHANGED | 0.00 | |
| PEN | PENUMBRA INC | 0.34 | 7,500 | 1,886,550 | NEW | ||
| PMN | PROMIS NEUROSCIENCES INC | 0.06 | 265,958 | 305,852 | UNCHANGED | 0.00 | |
| PODD | INSULET CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PRTA | PROTHENA CORP PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RCKT | ROCKET PHARMACEUTICALS INC | 0.01 | 75,000 | 36,750 | UNCHANGED | 0.00 | |
| RLAY | RELAY THERAPEUTICS INC | 0.60 | 300,000 | 3,303,000 | NEW | ||
| ROIV | ROIVANT SCIENCES LTD | 1.03 | 500,000 | 5,615,000 | ADDED | 233 | |
| SGEN | SEAGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SVRA | SAVARA INC | 0.99 | 1,150,000 | 5,405,000 | UNCHANGED | 0.00 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 0.67 | 100,000 | 3,650,000 | ADDED | 140 | |
| TALS | TALARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TERN | TERNS PHARMACEUTICALS INC | 0.08 | 66,000 | 428,340 | REDUCED | -79.69 | |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 3.62 | 1,900,000 | 19,836,000 | REDUCED | -5.00 | |
| THRX | THESEUS PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TNGX | TANGO THERAPEUTICS INC | 0.54 | 300,274 | 2,972,710 | REDUCED | -14.21 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VKTX | VIKING THERAPEUTICS INC | 1.02 | 300,000 | 5,583,000 | UNCHANGED | 0.00 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 0.20 | 50,000 | 1,089,000 | NEW | ||
| VRNA | VERONA PHARMA PLC | 2.05 | 563,824 | 11,208,800 | ADDED | 53.08 | |
| XENE | XENON PHARMACEUTICALS INC | 3.87 | 460,000 | 21,187,600 | ADDED | 53.11 | |
| APOGEE THERAPEUTICS INC | 2.74 | 537,093 | 15,006,400 | REDUCED | -48.61 | ||
| TOURMALINE BIO INC | 0.33 | 68,081 | 1,782,360 | NEW | |||
| BIOHAVEN LTD | 0.16 | 20,866 | 893,065 | REDUCED | -30.81 |